FDA Drug Application (062645) for ULTRAGRIS-165 by PLIVA

Back to FDA Applications sponsored by PLIVA

Application Number062645
Product Number001
FormTABLET;ORAL
Dosage165MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameULTRAGRIS-165
Active IngredientGRISEOFULVIN, ULTRAMICROCRYSTALLINE

Active IngredientCount
List of drugs with Active Ingredient GRISEOFULVIN, ULTRAMICROCRYSTALLINE6


Back to FDA Applications sponsored by PLIVA